Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Batch Record Review and Approval

Posted on By

SOP for Batch Record Review and Approval

Standard Operating Procedure for Batch Record Review and Approval in Vaginal Dosage Form Manufacturing

1) Purpose

The purpose of this SOP is to define the procedure for reviewing and approving batch records to ensure compliance with established specifications and GMP requirements for vaginal dosage forms.

2) Scope

This SOP applies to the Quality Assurance (QA) Department responsible for reviewing and approving batch records for all batches of vaginal dosage forms manufactured at the facility.

3) Responsibilities

The QA Department is responsible for reviewing batch records to verify accuracy, completeness, and compliance with approved procedures and specifications. The Production Department is responsible for providing accurate and timely batch records for review.

See also  SOP for Packaging Material Storage

4) Procedure

4.1 Receipt of Batch Records

  1. Receive batch records from the Production Department after completion of manufacturing and packaging.
  2. Verify that all required sections of the batch record are completed, including critical parameters, in-process controls, and packaging details.

4.2 Review of Batch Records

  1. Conduct a thorough review of the batch record to ensure compliance with approved procedures, specifications, and GMP requirements.
  2. Verify accuracy of entries, including dates, times, signatures, and any deviations or corrective actions documented.

4.3 Documentation and Corrections

  1. Document findings and observations during the review process.
  2. Identify any discrepancies or non-conformances and communicate them to the Production
Department for clarification or corrective action.

4.4 Approval of Batch Records

  1. Once all discrepancies are resolved and the batch record is deemed compliant, approve the batch record.
  2. Sign and date the batch record to indicate approval.

5) Abbreviations, if any

GMP: Good Manufacturing Practice; QA: Quality Assurance

6) Documents, if any

Batch record checklist, non-conformance report, deviation log

7) Reference, if any

ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, WHO Technical Report Series No. 961, Annex 2: WHO guidelines on good manufacturing practices for pharmaceutical products

8) SOP Version

Version 1.0

See also  SOP for Validation Protocols (IQ, OQ, PQ)
Vaginal Dosage Forms Tags:Audit trail SOP for vaginal dosage forms, Batch record review SOP for vaginal formulations, Batch release procedure for vaginal gels, Change control SOP for vaginal products, Cleaning validation SOP for vaginal equipment, Complaint handling SOP for vaginal products, Deviation handling SOP for vaginal dosage forms, Documentation control SOP for vaginal SOPs, environmental monitoring in vaginal manufacturing, Filling suppositories, GMP SOP for vaginal gel manufacturing, Labeling SOP for vaginal medicines, Mixing SOP for vaginal formulations, Packaging SOP for vaginal dosage forms, Procedure for vaginal ring production, Process validation SOP for vaginal preparations, Quality control SOP for vaginal tablets, Risk assessment SOP for vaginal manufacturing, SOP for emergency response in vaginal production, SOP for filling vaginal suppositories, SOP for vaginal cream formulation, SOP for vaginal dosage forms, SOP for vaginal medications, SOP for vaginal production, Stability testing SOP for vaginal rings, Sterility testing SOP for vaginal products, Suppository SOP, Training program for vaginal product manufacturing, Vaginal suppository manufacturing SOP, Vaginal tablet production guidelines, Validation protocol for vaginal creams, Vendor qualification SOP for vaginal ingredients

Post navigation

Previous Post: SOP for Automatic Gel Filling Machine
Next Post: SOP for Stability Testing Equipment

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version